Nucleic Acid Amplification Detection And Diagnostics Market Scope And Analysis

  • Report Code : TIPRE00016305
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Nucleic Acid Amplification, Detection, and Diagnostics Market Analysis, Size, and Growth (2023-2031)

Buy Now


Nucleic Acid Amplification, Detection, and Diagnostics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 16.7 Billion
Market Size by 2031 US$ 42.2 Billion
Global CAGR (2023 - 2031) 12.7%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Nucleic Acid
  • DNA and RNA
By Process
  • Amplification
  • Detection
  • Diagnostics
By Product Type
  • Assays
  • Kits & Reagents
  • Systems
By Technology
  • PCR
  • Isothermal Amplification Technology
  • Direct Nucleic Acid Detection
  • NGS
  • CRISPR-Cas9
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BD
  • bioMeriux SA
  • BIO RAD LABORATORIES INC
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Danaher
  • QIAGEN
  • Abbott
  • Meridian Bioscience Inc
  • F Hoffmann La Roche Ltd
  • Nucleic Acid Amplification, Detection, and DiagnosticsMarket News and Recent Developments

    The Nucleic Acid Amplification, Detection, and DiagnosticsMarket is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for Nucleic Acid Amplification, Detection, and Diagnostics:

    • In September 2022, Mylab announced the launching of "PathoDetect HPV," a real-time PCR-based screening solution to detect high-risk types of HPV among individuals. Additionally, the company plans to introduce an extension of this kit that can simultaneously detect upto 15 high-risk along with discrimination of HPV 16 & 18, covering more than 95% of cases of cervical cancer.

    Nucleic Acid Amplification, Detection, and DiagnosticsMarket Report Coverage and Deliverables

    The “Nucleic Acid Amplification, Detection, and DiagnosticsMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles